T. Rowe Price Associates’s Cantel Medical Corporation CMD Stock Holding History

T. Rowe Price Associates’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-526,211	Closed	-$42M	–	2967
2021 Q1	$42M	Sell	526,211 -15,991	-3%	-$1.28M	﹤0.01%	1060
2020 Q4	$42.8M	Sell	542,202 -3,465	-0.6%	-$273K	﹤0.01%	1010
2020 Q3	$24M	Buy	545,667 +12,517	+2%	+$550K	﹤0.01%	1105
2020 Q2	$23.6M	Sell	533,150 -2,415	-0.5%	-$107K	﹤0.01%	1101
2020 Q1	$19.2M	Sell	535,565 -57,397	-10%	-$2.06M	﹤0.01%	1085
2019 Q4	$42M	Sell	592,962 -2,473	-0.4%	-$175K	0.01%	973
2019 Q3	$44.5M	Sell	595,435 -3,288	-0.5%	-$246K	0.01%	912
2019 Q2	$48.3M	Sell	598,723 -2,901	-0.5%	-$234K	0.01%	907
2019 Q1	$40.2M	Sell	601,624 -3,672	-0.6%	-$246K	0.01%	956
2018 Q4	$45.1M	Buy	605,296 +7,304	+1%	+$544K	0.01%	868
2018 Q3	$55.1M	Buy	597,992 +40,260	+7%	+$3.71M	0.01%	879
2018 Q2	$54.9M	Buy	557,732 +117,643	+27%	+$11.6M	0.01%	862
2018 Q1	$49M	Buy	440,089 +28,172	+7%	+$3.14M	0.01%	880
2017 Q4	$42.4M	Buy	411,917 +9,240	+2%	+$951K	0.01%	918
2017 Q3	$37.9M	Buy	402,677 +19,378	+5%	+$1.82M	0.01%	952
2017 Q2	$29.9M	Buy	383,299 +15,570	+4%	+$1.21M	0.01%	1022
2017 Q1	$29.5M	Buy	367,729 +41,030	+13%	+$3.29M	0.01%	1004
2016 Q4	$25.7M	Buy	326,699 +18,900	+6%	+$1.49M	0.01%	1052
2016 Q3	$24M	Buy	307,799 +31,687	+11%	+$2.47M	﹤0.01%	1069
2016 Q2	$19M	Buy	276,112 +17,922	+7%	+$1.23M	﹤0.01%	1117
2016 Q1	$18.4M	Buy	258,190 +36,400	+16%	+$2.6M	﹤0.01%	1111
2015 Q4	$13.8M	Buy	221,790 +212,190	+2,210%	+$13.2M	﹤0.01%	1203
2015 Q3	$544K	Hold	9,600	–	–	﹤0.01%	1913
2015 Q2	$515K	Hold	9,600	–	–	﹤0.01%	1982
2015 Q1	$456K	Buy	9,600 +3,200	+50%	+$152K	﹤0.01%	2016
2014 Q4	$277K	Sell	6,400 -1,500	-19%	-$64.9K	﹤0.01%	2210
2014 Q3	$272K	Hold	7,900	–	–	﹤0.01%	2188
2014 Q2	$289K	Hold	7,900	–	–	﹤0.01%	2200
2014 Q1	$266K	Buy	7,900 +400	+5%	+$13.5K	﹤0.01%	2211
2013 Q4	$254K	Hold	7,500	–	–	﹤0.01%	2222
2013 Q3	$239K	Buy	+7,500	New	+$239K	﹤0.01%	2200